Skip to main content
letter
. 2015 Jan 15;191(2):233–236. doi: 10.1164/rccm.201407-1365LE

Table 2.

Decline in Lung Function Based on Baseline Calprotectin Level

  Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 Per Twofold Increment in Baseline Calprotectin P Value
Median calprotectin, μg/ml 4.9 6.6 10.9 16.7 24.2
FEV1, ml              
 Unadjusted −35 84 0 186 68 33 (–2 to 68) 0.06
 Adjusted* −59 66 −51 195 65 44 (3 to 84) 0.03
FVC, ml              
 Unadjusted −14 54 −22 134 175 51 (21 to 81) <0.001
 Adjusted* −78 −17 −122 88 89 50 (12 to 87) 0.009

The rate of lung function decline per year increases with increasing baseline calprotectin. Data are presented for both unadjusted and adjusted (for age, sex, previous exacerbation rate, symptom score, and high-sensitivity CRP).

*

Note that three patients did not have a baseline high-sensitivity CRP model and were excluded from the analysis for this model.